ArriVent BioPharma (AVBP) Shares Outstanding (Diluted) (2023 - 2026)
ArriVent BioPharma (AVBP) Shares Outstanding (Diluted) (2023 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 52.24 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.51 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 10.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 256.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 680.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 64.41 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 198.10 Mn |
| 10 | ArriVent BioPharma | 1.42 Bn | 1.42 Bn | - | 45.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.07 Mn |
| Dec 31, 2025 | 38.46 Mn |
| Sep 30, 2025 | 41.91 Mn |
| Jun 30, 2025 | 35.01 Mn |
| Mar 31, 2025 | 33.90 Mn |
| Dec 31, 2024 | 31.47 Mn |
| Sep 30, 2024 | 33.58 Mn |
| Jun 30, 2024 | 33.50 Mn |
| Mar 31, 2024 | 25.05 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 2.61 Mn |
| Jun 30, 2023 | 2.00 Mn |
| Mar 31, 2023 | 1.29 Mn |